Doug Langa
Corporate Officer/Principal bei NOVO NORDISK A/S
Profil
Douglas Langa is currently the EVP & Head-North America Operations at Novo Nordisk A and the President, EVP & Head-North America Operations at Novo Nordisk, Inc. Prior to his current positions, he worked as the Director-Payer Marketing at GlaxoSmithKline Pharma A from 2009 to 2011.
Mr. Langa holds an MBA degree from Fordham University, which he obtained in 1997.
He also completed his undergraduate studies at Widener University in 1989.
Aktive Positionen von Doug Langa
Unternehmen | Position | Beginn |
---|---|---|
NOVO NORDISK A/S | Corporate Officer/Principal | 01.01.2011 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | President | 02.03.2017 |
Ehemalige bekannte Positionen von Doug Langa
Unternehmen | Position | Ende |
---|---|---|
GlaxoSmithKline Pharma A/S
GlaxoSmithKline Pharma A/S Medical DistributorsDistribution Services GlaxoSmithKline Pharma A/S operates as a science-led global healthcare company. It develops and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company was founded on December 11, 1968 and is headquartered in Brondby, Denmark. | Sales & Marketing | 01.01.2011 |
Ausbildung von Doug Langa
Fordham University | Masters Business Admin |
Widener University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NOVO NORDISK A/S | Health Technology |
Private Unternehmen | 2 |
---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
GlaxoSmithKline Pharma A/S
GlaxoSmithKline Pharma A/S Medical DistributorsDistribution Services GlaxoSmithKline Pharma A/S operates as a science-led global healthcare company. It develops and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company was founded on December 11, 1968 and is headquartered in Brondby, Denmark. | Distribution Services |